NCT06436560
Support for Transgender and Non-Binary Individuals Seeking Vaginoplasty Study
Enrolling by Invitation
NAAges 18+InterventionalHealth servicesOregon Health and Science UniversityInvestigator-initiated
~290 participants
Updated 2026-03-16 on ClinicalTrials.gov
What's tested:STRIVE Peer Support Intervention
At a glance
Recruiting sites
0 of 9 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient-reported coping self-efficacy as assessed by the CSES
Measured over Enrollment, 6 months after enrollment, 12 months after enrollment, immediate pre-operative, 3 months post-operative, 6 months post-operative
Conditions
Where it's being run
9 sites across 9 statesCalifornia1
Illinois1
Michigan1
Minnesota1
New York1
Oregon1
Pennsylvania1
Utah1
Study leadership
- Geolani Dy, MD · PRINCIPAL_INVESTIGATOR · Oregon Health and Science University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Self-identified trans or non-binary individual
Seeking vaginoplasty
Completed consultation with gender-affirming surgeon for vaginoplasty
Documented recommendation by surgeon for vaginoplasty
Can complete survey responses online, by phone or on paper.
Willing and able to participate in virtual peer support intervention
Aged 18 or older
English speaking
Able to provide independent written consent
Exclusion
Do not speak English
Cannot complete survey responses online, by phone, or on paper
Are unwilling to participate in a virtual peer support intervention
Have co-morbidities or other conditions that exclude them from candidacy for vaginoplasty
Are currently involved in delivery of the STRIVE Intervention
Are unable or unwilling to participate.
What this trial measures
- Patient-reported coping self-efficacy as assessed by the CSESEnrollment, 6 months after enrollment, 12 months after enrollment, immediate pre-operative, 3 months post-operative, 6 months post-operative
Patient-reported coping self-efficacy is measured using the Coping Self-Efficacy Scale (CSES), a survey that assesses the perceived ability to deal with stressors using a score range of 0-260. Zero is equivalent to no perceived ability to deal with stressors; 260 indicates the highest attainable level of perceived ability to deal with stressors.